27775803|t|Long noncoding RNA PVT1 as a novel serum biomarker for detection of cervical cancer
27775803|a|To investigate long noncoding RNA PVT1 expression in the serum of cervical cancer patients, and to evaluate serum PVT1 level as a diagnostic biomarker for cervical cancer. Eighty-eight cervical cancer patients, 64 cervical intraepithelial neoplasia patients, 25 breast cancer patients, 25 ovarian cancer patients, and 111 healthy control subjects were enrolled into this study. PVT1 serum level in these participants and PVT1 expression in 20 pairs of cervical cancer tissues and adjacent paired normal tissues was measured by quantitative reverse transcription-polymerase chain reaction. The diagnostic values of serum PVT1 were evaluated by receiver operating characteristic curves analysis. Serum PVT1 level is significantly increased in cervical cancer patients and correlated with tumor size, clinical stage, and lymph node metastasis of cervical cancer. Serum PVT1 could accurately discriminate cervical cancer patients from cervical intraepithelial neoplasia patients and healthy control subjects, and also discriminate early stage cervical cancer patients from healthy control subjects. But serum PVT1 level is not changed in breast cancer and ovarian cancer patients. Furthermore, serum PVT1 level is positively correlated with tissue PVT1 expression, and could indicate cervical cancer dynamics. Long noncoding RNA PVT1 may be a novel noninvasive biomarker for early diagnosis of cervical cancer.
27775803	0	23	Long noncoding RNA PVT1	T017	UMLS:C0812285
27775803	35	40	serum	T031	UMLS:C0229671
27775803	41	50	biomarker	T201	UMLS:C0005516
27775803	68	83	cervical cancer	T038	UMLS:C4048328
27775803	99	122	long noncoding RNA PVT1	T017	UMLS:C0812285
27775803	141	146	serum	T031	UMLS:C0229671
27775803	150	165	cervical cancer	T038	UMLS:C4048328
27775803	192	197	serum	T031	UMLS:C0229671
27775803	198	202	PVT1	T103	UMLS:C0919548
27775803	225	234	biomarker	T201	UMLS:C0005516
27775803	239	254	cervical cancer	T038	UMLS:C4048328
27775803	269	284	cervical cancer	T038	UMLS:C4048328
27775803	298	332	cervical intraepithelial neoplasia	T038	UMLS:C0206708
27775803	346	359	breast cancer	T038	UMLS:C0678222
27775803	373	387	ovarian cancer	T038	UMLS:C0029925
27775803	462	466	PVT1	T103	UMLS:C0919548
27775803	467	472	serum	T031	UMLS:C0229671
27775803	505	509	PVT1	T017	UMLS:C0812285
27775803	536	551	cervical cancer	T038	UMLS:C4048328
27775803	624	671	reverse transcription-polymerase chain reaction	T062	UMLS:C0599161
27775803	698	703	serum	T031	UMLS:C0229671
27775803	704	708	PVT1	T103	UMLS:C0919548
27775803	778	783	Serum	T031	UMLS:C0229671
27775803	784	788	PVT1	T103	UMLS:C0919548
27775803	825	840	cervical cancer	T038	UMLS:C4048328
27775803	870	880	tumor size	T082	UMLS:C0475440
27775803	902	923	lymph node metastasis	T038	UMLS:C0686619
27775803	927	942	cervical cancer	T038	UMLS:C4048328
27775803	944	949	Serum	T031	UMLS:C0229671
27775803	950	954	PVT1	T103	UMLS:C0919548
27775803	985	1000	cervical cancer	T038	UMLS:C4048328
27775803	1015	1049	cervical intraepithelial neoplasia	T038	UMLS:C0206708
27775803	1123	1138	cervical cancer	T038	UMLS:C4048328
27775803	1183	1188	serum	T031	UMLS:C0229671
27775803	1189	1193	PVT1	T103	UMLS:C0919548
27775803	1274	1279	serum	T031	UMLS:C0229671
27775803	1280	1284	PVT1	T103	UMLS:C0919548
27775803	1328	1332	PVT1	T017	UMLS:C0812285
27775803	1364	1379	cervical cancer	T038	UMLS:C4048328
27775803	1390	1413	Long noncoding RNA PVT1	T017	UMLS:C0812285
27775803	1429	1440	noninvasive	T170	UMLS:C2986496
27775803	1441	1450	biomarker	T201	UMLS:C0005516
27775803	1455	1470	early diagnosis	T058	UMLS:C0596473
27775803	1474	1489	cervical cancer	T038	UMLS:C4048328